Baseline DCP levels and NLR predict survival in patients receiving atezolizumab+bevacizumab for advanced HCCSeptember 19, 2022Hepatocellular Carcinoma
First-line lenvatinib+toripalimab+FOLFOX-HAIC shows promise in high-risk advanced HCCSeptember 19, 2022Hepatocellular Carcinoma
HCC: Averting post-TARE hepatic decompensation with careful patient selection September 19, 2022Hepatocellular Carcinoma
Postoperative adjuvant TACE efficacy in HCC depends on micronecrosis stateSeptember 19, 2022Hepatocellular Carcinoma
Unresectable HCC: Atezolizumab+bevacizumab more effective in patients with good liver functionSeptember 19, 2022Hepatocellular Carcinoma
Advanced HCC with macroscopic PVTT: Hepatectomy offers better survival than sorafenibSeptember 19, 2022Hepatocellular Carcinoma
Transradial vs transfemoral access for TACE improves patient satisfaction in HCCSeptember 19, 2022Hepatocellular Carcinoma
CP-A to CP-B progression after lenvatinib initiation in HCC should not halt therapySeptember 19, 2022Hepatocellular Carcinoma
Sintilimab plus IBI305: A promising treatment option for advanced HCCSeptember 19, 2022Hepatocellular Carcinoma
Game-changing results in fluid resuscitation for acute pancreatitisSeptember 16, 2022Pancreas and Biliary Tract
